BEVACIZUMAB AND PLATINUM-BASED CHEMOTHERAPY IN RELAPSED OVARIAN CANCER TREATMENT

被引：0
|
作者：
Davidenko, I. [1 ]
Kazantseva, M. [1 ]
Porhanova, N. [1 ]
Potemin, S. [1 ]
Oganyan, M. [1 ]
Syrota, L. [1 ]
Shmatkova, V. [1 ]
机构：
[1] Reg Oncol Ctr, Krasnodar, Russia
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2013年 / 23卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Profiles of ovarian cancer patients that benefit from taxane-platinum and platinum-based chemotherapy
    Markowska, J.
    Bidziaski, M.
    Stelmachow, J.
    Kraszewska, E.
    Ziolkowska-Seta, I.
    Madry, R.
    Timorek, A.
    Rembiszewska, A.
    Kupryjaaczyk, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [22] Treatment of recurrent ovarian cancer relapsing 6-12 months post platinum-based chemotherapy
    Colombo, Nicoletta
    Gore, Martin
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2007, 64 (02) : 129 - 138
  • [23] Major Clinical Impact of Platinum-Based Chemotherapy in a Patient with a Borderline Ovarian Cancer
    Chen, Jian
    Markman, Maurie
    CASE REPORTS IN ONCOLOGY, 2009, 2 (03): : 168 - 171
  • [24] Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy
    Matsumoto, Aya
    Higuchi, Toshihiro
    Yura, Shigeo
    Mandai, Masaki
    Kariya, Masatoshi
    Takakura, Kenji
    Fujii, Shingo
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, 2006, 32 (06) : 580 - 587
  • [25] Comprehensive analysis for the immune related biomarkers of platinum-based chemotherapy in ovarian cancer
    Liu, Jiao
    Liu, Yaoyao
    Yang, Chunjiao
    Liu, Jingjing
    Hao, Jiaxin
    TRANSLATIONAL ONCOLOGY, 2023, 37
  • [26] Platinum-based neoadjuvant chemotherapy for advanced ovarian cancer: A meta-analysis
    Bristow, Robert E.
    Chi, Dennis S.
    GYNECOLOGIC ONCOLOGY, 2007, 106 (01) : 274 - 275
  • [27] Effectiveness of platinum-based chemotherapy among elderly patients with advanced ovarian cancer
    Hershman, D
    Jacobson, JS
    McBride, R
    Mitra, N
    Sundararajan, V
    Grann, VR
    Neugut, AI
    GYNECOLOGIC ONCOLOGY, 2004, 94 (02) : 540 - 549
  • [28] NCALD as a potential predictive biomarker for the efficacy of platinum-based chemotherapy in ovarian cancer
    Konrad, Sarah M.
    Schwamborn, Kristina
    Krueger, Achim
    Honert, Katja
    Schmitt, Manfred
    Hellmann, Daniela
    Schmalfeldt, Barbara
    Meindl, Alfons
    Kiechle, Marion
    Quante, Anne S.
    Brambs, Christine
    Grill, Sabine
    Ramser, Juliane
    BIOMARKERS IN MEDICINE, 2022, 16 (14) : 1029 - 1041
  • [29] Platinum-based chemotherapy and bevacizumab instigate the destruction of human ovarian cancers via different signaling pathways
    Kingnate, Chalita
    Charoenkwan, Kittipat
    Kumfu, Sirinart
    Apaijai, Nattayaporn
    Jaiwongkam, Thidarat
    Khunamornpong, Surapan
    Chattipakorn, Nipon
    Chattipakorn, Siriporn C.
    BIOCHEMICAL PHARMACOLOGY, 2021, 188
  • [30] Phase II OVARIO study of niraparib plus bevacizumab therapy in advanced ovarian cancer following front-line platinum-based chemotherapy with bevacizumab
    Hardesty, M. M.
    Krivak, T.
    Wright, G. S.
    Hamilton, E.
    Fleming, E. L.
    Gupta, D.
    Keeton, E.
    Chen, J.
    Clements, A.
    Gray, H. J.
    Konecny, G. E.
    Moore, R. G.
    Richardson, D. L.
    GYNECOLOGIC ONCOLOGY, 2020, 159 : 3 - 4
12345